A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-67856633, an Inhibitor of MALT1, in Participants with NHL and CLL

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/50334/MonH-2019-171988(v2)
NMA SSA Reference Number: SSA/50334/MonH-2019-173892(v1)
Monash Health Ref Number: RES-19-0000-097A
Effective start/end date3/06/192/06/24


  • clinical trial
  • treatment efficacy
  • lymphoma